China SXT Pharmaceuticals (SXTC) Price to Book (2026)
China SXT Pharmaceuticals (SXTC) posted Price to Book of 0.0 for Q1 2026.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Price to Book (2026) Analysis & Trends
China SXT Pharmaceuticals has reported Price to Book for 1 years, with the latest figure at 0.0 in Q1 2026.
- On a quarterly basis, Price to Book changed N/A year-over-year to 0.0 in Q1 2026; TTM through Mar 2026 was 0.0, a N/A change from a year earlier, with the FY2026 full-year figure at 0.0, changed N/A from the prior year.
- Price to Book was 0.0 for Q1 2026 at China SXT Pharmaceuticals.
- The five-year high for Price to Book was 0.0 in Q1 2026, with the low at 0.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn |
| 10 | China SXT Pharmaceuticals | 18,691.20 | -28.16 Mn | - |